• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

    1/26/24 4:54:19 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care
    Get the next $UFPT alert in real time by email
    SC 13G/A 1 UFPT13GFINAL01232024.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _3__)* UFP Technologies, Inc. (Name of Issuer) Common (Title of Class of Securities) 902673102 (CUSIP Number) December 31st, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. 902673102 1 Names of Reporting Persons AltraVue Capital, LLC 2 Check the appropriate box if a member of a Group (see instructions) (a) [ ] (b) [ ] 3 Sec Use Only 4 Citizenship or Place of Organization Delaware, US Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 30,310 6 Shared Voting Power 178,374 7 Sole Dispositive Power 208,684 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned by Each Reporting Person 208,684 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) [ ] 11 Percent of class represented by amount in row (9) 2.73% 12 Type of Reporting Person (See Instructions) IA Item 1. (a) Name of Issuer: UFP Technologies, Inc. (b) Address of Issuer?s Principal Executive Offices: 100 Hale Street Newburyport, MA 01950 / USA Item 2. (a) Name of Person Filing: AltraVue Capital, LLC (b) Address of Principal Business Office or, if None, Residence: 11747 NE 1st Street, Suite 205 Bellevue, WA 98005-3018 (c) Citizenship: USA (d) Title and Class of Securities: Common (e) CUSIP No.: 902673102 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [_] Broker or dealer registered under Section 15 of the Act; (b) [_] Bank as defined in Section 3(a)(6) of the Act; (c) [_] Insurance company as defined in Section 3(a)(19) of the Act; (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940; (e) X An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); (k) [_] Group, in accordance with Rule 240.13d- 1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d- 1(b)(1)(ii)(J), please specify the type of institution: ____ Item 4. Ownership (a) Amount Beneficially Owned: 208,684 (b) Percent of Class: 2.73% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote:30,310 (ii) Shared power to vote or to direct the vote: 178,374 (iii) Sole power to dispose or to direct the disposition 208,684 of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ X ]. Item 6. Ownership of more than Five Percent on Behalf of Another Person. Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. Item 8. Identification and classification of members of the group. Item 9. Notice of Dissolution of Group. Item 10. Certifications. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Dated: January 23rd, 2024 /s/ Signature Tom Parkhurst / COO & CCO Name/Title The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    Get the next $UFPT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UFPT

    DatePrice TargetRatingAnalyst
    3/28/2025Mkt Perform
    Raymond James
    7/17/2024$344.00 → $392.00Buy
    Lake Street
    3/20/2024Market Outperform
    CJS Securities
    2/6/2024Sector Weight
    KeyBanc Capital Markets
    12/21/2022$124.00Buy
    Lake Street
    6/22/2022$110.00Buy
    Lake Street
    11/19/2021$81.00Buy
    Colliers Securities
    More analyst ratings

    $UFPT
    Leadership Updates

    Live Leadership Updates

    See more
    • UFP Technologies Acquires AQF Medical

      NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.

      8/26/24 9:00:00 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Acquires Marble Medical

      NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi

      7/16/24 4:05:00 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Chimerix Appoints Marc D. Kozin to Board of Directors

      DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo

      3/21/24 7:00:00 AM ET
      $CMRX
      $UFPT
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Dental Instruments

    $UFPT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UFP Technologies Announces Record Q1 Results

      NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n

      5/6/25 9:00:56 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025

      NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time. Conference Call Information:Date: Tuesday, May 6, 2025Time: 10:00 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live webcast of t

      4/30/25 9:00:43 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum

      NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18, 2025. UFP's presentation is scheduled to begin at 10:30 AM ET. About UFP Technologies, Inc.UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engine

      3/17/25 9:00:01 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    SEC Filings

    See more

    $UFPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $UFPT
    Financials

    Live finance-specific insights

    See more

    $UFPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $UFPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 144 filed by UFP Technologies Inc.

      144 - UFP TECHNOLOGIES INC (0000914156) (Subject)

      5/8/25 3:49:36 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

      5/7/25 8:39:37 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form DEF 14A filed by UFP Technologies Inc.

      DEF 14A - UFP TECHNOLOGIES INC (0000914156) (Filer)

      4/30/25 12:05:31 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Vice President Holt Jason covered exercise/tax liability with 462 shares, decreasing direct ownership by 6% to 7,848 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      3/5/25 8:02:14 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Vice President Cardin Steve covered exercise/tax liability with 623 shares, decreasing direct ownership by 10% to 5,623 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      3/5/25 7:59:35 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Senior Vice President Litterio Christopher P. covered exercise/tax liability with 921 shares, decreasing direct ownership by 6% to 14,058 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      3/5/25 7:54:06 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Announces Record Q1 Results

      NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n

      5/6/25 9:00:56 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025

      NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time. Conference Call Information:Date: Tuesday, May 6, 2025Time: 10:00 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live webcast of t

      4/30/25 9:00:43 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025

      NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th. About UFP Technologies, Inc. UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to man

      2/19/25 9:00:38 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by UFP Technologies Inc.

      SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

      11/13/24 9:58:23 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

      SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)

      3/8/24 3:02:25 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by UFP Technologies Inc.

      SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

      2/13/24 5:16:09 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Lataille Ronald J bought $91,636 worth of shares (400 units at $229.09), increasing direct ownership by 3% to 15,031 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      2/27/25 3:57:17 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Lataille Ronald J

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      11/13/23 11:09:49 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Rock Mitchell bought $27,522 worth of shares (198 units at $139.00), increasing direct ownership by 0.74% to 27,086 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      11/9/23 5:21:17 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on UFP Technologies

      Raymond James initiated coverage of UFP Technologies with a rating of Mkt Perform

      3/28/25 8:21:18 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Lake Street reiterated coverage on UFP Technologies with a new price target

      Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously

      7/17/24 8:57:19 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • CJS Securities initiated coverage on UFP Technologies

      CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform

      3/20/24 9:43:53 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care